Emerging Markets Regulatory Tracker: Australia (Vol. 4 No. 52)
This article was originally published in PharmAsia News
Executive Summary
Australia’s Therapeutic Good Administration has sought comments for the first major revision of its 2001 Drug Labelling Regulations.